One of the world's leading experts in computational chemistry searches for the next great medicines and therapies at Stevens.
The university-wide Center for Healthcare Innovation (CHI) supports Stevens faculty- and student-initiated research and educational programs that address gaps and issues related to advancing biomedical technology and healthcare delivery, and also serves as a focal point for integration of external strategic partnerships.
The Center for Healthcare Innovation (CHI) was established as part of the Stevens 10-year strategic plan as a university-wide educational and research coordinating center to guide and augment the university’s impact in healthcare. It serves as a resource for over 60-affiliated faculty employing multidisciplinary approaches to advance medical technology and improve healthcare delivery through education, research, partnerships and commercialization. Internal research within the CHI is focused on drug discovery and tissue engineering.
Among its diverse activities, the CHI aims to:
Additional activities of the CHI involve the coordination of multi-investigator grant and contract proposals, and the commercialization of intellectual property.
Major areas of research managed by the CHI include tissue engineering of cancer biopsies for drug assessment and therapy selection; biomaterials that promote cell growth and control infection in implanted prosthetic and medical devices; drug discovery and development initiatives; mobile healthcare and telemedicine applications; and data analytics and modeling of healthcare delivery systems.
Please explore these pages to learn more about Stevens research and collaboration at the leading edge of healthcare and biomedical innovation.